by Orphagen Pharma | Jan 17, 2023 | News, Uncategorized
SAN DIEGO–(BUSINESS WIRE)–Orphagen Pharmaceuticals, Inc., a biotech company pioneering the screening, discovery, and development of small molecule ligands that modulate orphan or unexplored members of the nuclear receptor family, today announced that the...
